Patent ID: 11896352
Assignee: BAYER AKTIENGESELLSCHAFT
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 9:
10. A system comprising:
at least one sensor configured to determine, after a fluid injection associated with a patient is started, sensor data associated with the patient; and
at least one processor programmed and/or configured to:
determine, based on the sensor data determined after the fluid injection is started, a current risk prediction for the patient associated with the fluid injection, wherein the current risk prediction includes a probability that the patient experiences at least one adverse event in response to the fluid injection, and wherein the at least one adverse event includes: an extravasation, a post-contrast acute kidney injury, an acute adverse event, a contrast media induced nephrotoxicity, and a thyrotoxicosis such that the current risk prediction includes a probability that the patient experiences the extravasation, a probability that the patient experiences the post-contrast acute kidney injury, a probability that the patient experiences the acute adverse event, a probability that the patient experiences the contrast media induced nephrotoxicity, and a probability that the patient experiences the thyrotoxicosis; and
provide, to the user device, the current risk prediction, wherein the at least one processor is further programmed and/or configured to provide the current risk prediction by automatically controlling, in response to determining that the patient experiences the extravasation, the fluid injection system to stop the fluid injection.